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Abstract UV-A irradiation induces a time-dependent activation 
of AP-I in NCTC 2544 human keratinocytes. 4 h after 
irradiation, a 2-3-fold increase in AP-1 activity is observed in 
human keratinocytes and fibroblasts. Activation is stiff detect- 
able 24 h later. The UV-A induced AP-1 binding complex is 
shown to contain c-Fos and c-Jun proteins. Lipophilic vitamin E 
impedes UV-A induced lipid peroxidation but does not prevent 
AP-1 activation which is inhibited by N-acetylcysteine, a
hydrophilic antioxidant. This finding suggests that UV-A- 
dependent AP-1 activation is sensitive to the cellular redox state 
but is not related to membrane lipid peroxidation. 
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1. Introduction 
The ultraviolet spectral distribution of solar radiation at the 
Earth's surface includes short-wavelength UV-B light (290- 
320 nm) and long-wavelength UV-A light (320-400 nm). 
UV-B and UV-A have been shown to be involved in degen- 
erative changes in the skin related to aging and cancer [1,2]. 
UV-A is more abundant (96% of UV radiation) and more 
penetrating than UV-B, making it possible for UV-A to 
play an important role in dermal and epidermal damage. Tra- 
ditionally, many studies have been focused on UV-B and UV- 
C (e.g. wavelength in the range 100-290 nm), because these 
radiations can directly damage nucleic acids [3]. Much less 
attention has been paid to the potential contribution of solar 
UV-A which is expected to affect different cell components. 
Such damage is thought o result from a photodynamic a tion 
of UV-A, involving endogenous chromophores such as flavins 
or porphyrins [4], which produce reactive oxygen intermedi- 
ates (ROI) in the cell. The ROI can damage cells via lipid 
peroxidation and alteration of proteins and nucleic acids [5]. 
Indeed, exposure of mammalian cells to UV-A has been 
shown to result in alterations of protein kinase C activity 
[6], activation of phospholipases A2 and C [7], and lipid per- 
oxidation [8]. Recently, we have demonstrated that UV-A 
decreases receptor-mediated processing of low-density lipo- 
protein [9] and of epidermal growth factor in human fibro- 
blasts and keratinocytes [10]. Little is known about the effect 
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of UV-A on factors that regulate gene expression but the 
induction of NF-~cB DNA binding activity by UV-A was re- 
cently demonstrated in human fibroblasts [11]. Besides NF- 
KB, AP-1 is known as an oxidative stress-responsive transcrip- 
tion factor. 
The transcription factor AP-1 is composed of members of 
the Jun and Fos families which bind to PMA response le- 
ments or AP-1 sites. The AP-1 couples extracellular signals 
such as growth factors and PMA to changes in the program 
of gene expression associated with growth, differentiation a d 
cellular stress [12]. It has been shown that stimulation of AP-1 
by growth factors involves a cascade of kinase activation [13]. 
Several pathways and mechanisms, including c-fos and c-jun 
induction and post-translational modification of their pro- 
ducts, contribute to the induction of AP-1 activity. Recent 
results have demonstrated anincrease in AP-1 binding activity 
in response to a wide range of stresses, including ionizing 
radiation, heat shock and UV-C radiation [14,15]. These find- 
ings prompted us to investigate whether the UV-A induced 
oxidative stress was able to modulate the activity of AP-1 
binding sites and, if so, to examine the effect of antioxidants 
on this response. Here, we demonstrate a dose-dependent ac-
tivation of AP-1 after UV-A exposure of NCTC 2544 human 
keratinocytes. Vitamin E, a specific membrane lipid antioxi- 
dant, does not prevent the action of UV-A on AP-1 activation 
while N-acetylcysteine (Nac), a glutathione precursor, impairs 
this response. 
2. Materials and methods 
2.1. Reagents 
The double-stranded oligonucleotides containing the AP-1 sequence 
were synthesized on a 0.2 ~tmol scale by Eurogentec (Belgium). [y- 
32p]ATP was purchased from ICN (Orsay, France). T4 polynucleotide 
kinase was obtained from Boehringer Mannhein, (Meylan, France). 
Rabbit polyclonal antibodies against c-Fos and c-Jun subunits of AP- 
1 were provided by Santa Cruz Biotechnology, Inc. (CA, USA). The 
Oct-1 consensus oligonucleotide was synthesized byPromega (Char- 
bonni6res,France). All other eagents were purchased from Sigma (St. 
Louis, MO, USA). 
2.2. Cell culture 
The NCTC 2544 human keratinocyte c ll line [16] was purchased 
from ICN (Orsay, France) and the MRC5 human fetal ung fibro- 
blasts was obtained from BioM6rieux (Craponne, France). Cells were 
cultured at 37°C in Dulbecco's modified Eagle's Medium (DMEM, 
Gibco-BRL). supplemented with 10%o fetal calf serum and antibiotics 
(100 U/ml penicillin and 0.1 mg/ml streptomycin). Cultures were 
maintained at 37°C in a humidified 5% CO2 atmosphere. Prior to 
UV-A irradiation, cells were growth-arrested at subconfluence by a 
24 h incubation with serum-free DMEM supplemented with 0.1%o 
bovine serum albumin. 
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2.3. UV-A irradiation 
Ultraviolet-A radiation was carried out with a Vilber Lourmat able 
equipped with a TF-20L tube, emitting maximally at 365 nm, at a 
dose rate of 3 + 0.2 mW/cm 2. A piece of glass (4 mm thickness) was 
placed 20 mm above the table to absorb the majority of UV-B light 
(transmittance <0.01% at 310 nm). Before irradiation, cell monolayers 
were washed three times with PBS (phosphate buffer, saline) and 
covered in Hanks' salts. After irradiation with UVA doses as high 
as 190 kJ/m 2, cells were left for 1 h in the dark at 37°C. Then, the 
irradiation medium was replaced by serum-free medium until prepara- 
tion of nuclear extracts. Sham-irradiated control ceils were treated in 
a similar way but were not irradiated. 
2.4. TBARS measurement and effect of antioxidants 
Lipid peroxidation end products (TBARS), including malondialde- 
hyde (MDA), were measured after 1 h following cell irradiation. 
Measurements were performed on an aliquot of the supernatant of
irradiated or sham-irradiated cells, as it has been previously shown 
that most of the TBARS produced after UV-A exposure are secreted 
by cells [8]. The samples were assayed for TBARS, using the fluori- 
metric method of Yagi [17], with minor technical modifications [8]. In 
some experiments, the effects of the antioxidants vitamin E and N- 
acetylcysteine were studied. N-Acetylcysteine solution was adjusted to 
pH 7.4 with 1 M NaOH. This agent was added to cultures 2 h prior to 
irradiation at 3× 10 -2 M and then reintroduced with Hank's salt 
following irradiation. It is interesting to note that N-acetylcysteine 
solution had no significant absorption in the UV-A range. In studies 
where vitamin E was utilised, this antioxidant was added to cultures 
24 h prior to irradiation at 5 x 10 -~ M with serum-free DMEM sup- 
plemented with 0.1% bovine serum albumin. 
2.5. Preparation of nuclear extracts 
Nuclear extracts were prepared as described by Dignam et al. [18] 
with slight modification. Briefly, cells were harvested, pelleted and 
resuspended in 100 ~tl of 10 mM HEPES, 1.5 mM MgC12, 10 mM 
KCL, 0.5 mM dithiothreitol (DTT), 0.1% Nonidet P-40 supplemented 
with the following protease inhibitors: 0.2 mM phenylmethylsulfonyl 
floride, 2 ~tM aprotinin, 1 ~tg/ml antipain, pepstatin, benzamidine, and 
leupepetin. After homogenization in a tight-fitting Dounce homogeni- 
zer, cell lysates were left on ice for 10 min and then centrifuged at 
2000 × g for 30 min. The nuclear pellet was then washed with buffer A 
without Nonidet-40, and resuspended in 50 Ixl of 20 mM HEPES, pH 
7.9, 490 mM NaC1, 1.5 mM MgCI2, 0.2 mM EDTA, 0.5 mM DTT, 
25% glycerol, and incubated in the mixture of protease inhibitors 
described above. The suspension was gently shaken for 30 min at 
4°C. After centrifugation at 13 000 ×g, for 15 min, the nuclear extracts 
(supernatants) were collected and frozen in aliquots 15 ~tl at -80°C. 
2.6. Electrophoretic mobility shift assay (EMSA) 
Either strand of the AP-1 duplex was 32P-end labeled with T4 
polynucleotide kinase and [?-32P]ATP, according to the manufac- 
turer's protocol and then hybridized with its complementary strand. 
The binding reaction was performed for 25 min at room temperature 
with 3 5 p.g nuclear protein in 20 ~tl of 10 mM Tris-HC1 pH 7.5, 50 
mM NaCI, 0.5 mM DTT, 10% glycerol, 0.2% Nonidet P-40, and 3 ktg 
of poly(dI-dC). The solution contained 0.1 pmol of the end-labeled 
double-stranded AP-1 probe (2000040000 cpm). Where indicated, 
the incubation mixture also contained a large excess of a double- 
stranded unlabeled oligonucleotide containing either the AP-1 (speci- 
fic) or the OCT-1 (immunoglobulin e hancer octanucleotide factor-l, 
an unspecific double-stranded oligonucleotide of identical length) con- 
sensus equence. The binding mixtures were electrophoresed on a 6% 
non-denaturing polyacrylamide gel in 180 mM Tris, 180 mM borate, 
0.1 mM EDTA, pH 8.3, dried and analyzed with a phosphorimager 
instrument SP (Molecular Dynamics). For the characterization f the 
DNA binding proteins, nuclear proteins were incubated for 24 h at 
4°C with specific antibodies directed against c-Jun or c-Fos before the 
binding reaction was initiated. 
3. Results 
3.1. Activation of  AP-1 by UV-A 
The AP-1 activity was measured at different imes after UV- 
A exposure of NCTC 2544 human keratinocytes (Fig. 1). This 
activity was relatively low in controls (serum-starved cells), as 
shown by the weak intensity of the DNA-b ind ing complex 
band in the case of sham-irradiated cells. Rapid activation 
of AP-1 binding sites was already detectable 1 h after irradia- 
t ion at 190 kJ/m 2. 4 h after irradiation, the intensity of the 
DNA-binding complex band shown a maximal 3-fold increase 
as compared to sham-irradiated controls. Furthermore,  24 h 
after UV-A exposure, activation of AP-1 by UV-A was atte- 
nuated but was still higher than that of control cells. To 
approach the mechanism whereby UV-A induced AP-1, 
NCTC 2544 cells were treated before, during and after irra- 
diation with the protein synthesis inhibitor cycloheximide. In- 
terestingly, we observed that activation of AP-1 by UV-A 
measured 1 h after irradiation was preserved in the presence 
of cyloheximide (Fig. 1, last two lanes). 
Fig. 2A shows the effect of increasing UV-A doses on AP-1 
activity, measured 4 h after irradiation in human keratino- 
cytes NCTC 2544. Significant activation of AP-1 DNA bind- 
ing can be observed with low doses of UV-A (47.5 kJ/m2). 
The extent of activation was dose-dependent, with a reprodu- 
cible 2-3-fold enhancement a the maximal UV-A dose (190 
kJ/m2). Similarly, this UV-A dose increased the AP-1 activity 
by about  3-fold in human fibroblasts (MRC5 cell line, Fig. 
2B). 
T ime after  t reatment  
lh  2h  4h  24h  lh  
UV -+-  +-  +-  + - + 
cycloheximide . . . . . . . .  + + 
AP-1 
F ree ~:~ 
Fig. 1. Time course of AP-1 activation by UV-A. NCTC 2544 cells 
were treated with (+) or without ( - )  190 kJ/m 2 dose of UV-A and 
then harvested at different ime intervals after treatment. In the last 
two lanes, cells were incubated in the presence (+) of 10 I.tg/ml cy- 
cloheximide 2 h before irradiation. Following irradiation, the drug 
was reintroduced into the cultures. Nuclear extracts were prepared 
and assayed for AP-1 activity, as described in section 2. These data 
are representative of at least three independent experiments. The 
specific AP-1 DNA binding complex bands are indicated by 'AP-I' 
and the free probe bands are denoted by 'free'. 
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Table 1 
Effect of vitamin E and N-acetylcysteine on UV-A induced TBARS production and AP-1 activity 
TBARS formation (nmol/mg cell protein) AP-1 activity (%) 
N 0.3 + 0.015 100 
I 1.3 + 0.14 232 + 26 
I+vit E 0.4 + 0.03 240 + 17 
I+Nac 1.1 +0.1 131 + 16 
Prior to irradiation, ceils were incubated either for 24 h with 5 × 10 -5 M vitamin E or for 2 h with 3 x 10 -2 M Nac. Cells were irradiated with 
a dose of 190 kJ/m 2. TBARS were measured after 1 h of incubation at 37°C in the dark. Nuclear extracts were prepared 4 h after UV-A 
exposure. EMSA was performed as described under section 2. For TBARS, results are expressed as nmol MDA equivalents/mg of cell proteins. 
AP-1 activity is expressed as percentage of controls (N). N, unirradiated cells; I, irradiated cells; I+E, irradiated cells pre-treated with vitamin 
E; I+Nac, irradiated cells pre-treated with Nac. 
3.2. Characterization of the UV-A-induced AP-1-DNA 
complex 
The UV-A induced DNA-protein complex was character- 
ized (figure 3) using antibodies directed against he c-Jun (lane 
2) and c-Fos (lane 3) AP-1 subunits. Incubation of nuclear 
extracts with these antibodies markedly reduced the intensity 
of the DNA protein complex band indicating the presence of 
c-Jun and c-Fos in the UV-induced complexes. The specificity 
of the DNA-protein complex was further assessed by compe- 
tition experiments (figure 3). The binding to the oligonucleo- 
tide was strongly inhibited in the presence of a large excess of 
unlabeled oligonucleotide containing the AP-1 binding site 
(lane 4). No competition was detectable upon addition of a 
UV-A dose 
(kJ/m2) 0 47.5 95 190 190 
-+-+ -+ -+ 
large excess of non-specific double-stranded DNA containing 
the Oct-1 consensus equence (lane 5). 
3.3. Effect of  antioxidants on AP-1 activity 
Since UV-A exposure has been shown to induce membrane 
lipid peroxidation in fibroblasts and keratinocytes [8], we in- 
vestigated the role of lipid peroxidation i  UV-A induction of 
AP-1 activity. Therefore, the effects of a pre-treatment of cells 
with antioxidants uch as the lipophilic vitamin E and the 
hydrophilic N-acetylcysteine were studied. Table 1 shows 
that, under our conditions, vitamin E etiiciently reduced-by 
about 95% -the UVA-induced formation of lipid peroxidation 
products (TBARS). In contrast, this antioxidant did not pre- 
vent activation of AP-1 DNA binding activity by UV-A. On 
the other hand, N-acetylcysteine, which is readily taken up by 
cells and is rapidly converted to glutathione, did not impede 




Fig. 2. Dependence of AP-1 activation on UV-A doses. (A) NCTC 
2544 cells were treated with (+) or without ( - )  UV-A doses as indi- 
cated at the top of the figure and then left for 1 h at 37°C in the 
dark. Nuclear extracts were prepared 4 h after irradiation and as- 
sayed for AP-1 activity, as described under section 2. Data are from 
a typical experiment that was repeated three times. (B) MRC5 cells 
(human fibroblasts) were treated with (+) or without ( - )  UV-A at 
the maximum dose of 190 kJ/m 2, as indicated at the top of the fig- 
ure, and then treated as NCTC 2544 cells. 
The present work reports the effect of UV-A exposure on 
AP-1 binding activity in human keratinocytes which represent 
about 95% of all epidermal cells. Similar activation was ob- 
tained in human fibroblasts (figure 2B). Several conclusions 
can be drawn from this study. 
Firstly, UV-A exposure induces a time-dependent activation 
of AP-1. This effect is already observed 1 h after UV-A ex- 
posure, is maximal after 4 h and is still detectable 24 h later. 
The mechanism whereby UV-A induces AP-1 activation is 
unknown but the finding that AP-1 activation occurs within 
the first hour of irradiation argues for a post-translational 
effect of UV-A on AP-1 activity. Moreover, treatment of cells 
before, during and after irradiation with cycloheximide, a
protein synthesis inhibitor, maintains the UV-A activation 
of AP-1 measured 1 h after UV-A exposure, suggesting that 
this process did not require de novo protein synthesis at least 
over this time (see figure 1, right lanes). However, it cannot be 
excluded that the mechanism of activation of AP-1 at longer 
times such as 24 h after irradiation may involve more complex 
processes. 
Secondly, UV-A exposure induces a dose-dependent in- 
crease in AP-1 binding activity. A significant effect is observed 
at a very low irradiation dose of 47.5 kJ/m 2. Furthermore, 
considerable activation of AP-1 is obtained at the maximal 
UV-A dose used in this study (190 kJ/m2). Moreover, similar 
results are obtained with human fibroblasts (MRC5) suggest- 
ing that UV-A dependent activation of AP-1 is not a cell-type 
specific response. It is interesting to note that a UV-A dose of 
190 kJ/m 2 is not cytotoxic towards these two types of cell lines 
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[19] and corresponds to only about 1/3 of the UV-A minimal 
erythemal dose for a phototype I subject (i.e., white cauca- 
sian). 
Thirdly, vitamin E totally inhibits UV-A induced lipid per- 
oxidation formation but does not prevent he increase in AP-1 
activity. In addition, a significant activation of AP-1 is ob- 
served at low UV-A doses, where no TBARS are produced 
(data not shown). Together, these findings suggest hat no 
correlation can be drawn between UV-A-induced peroxidative 
membrane damage and UV-A-enhanced AP-1 binding activ- 
ity. Furthermore, we show here that, in contrast o vitamin E, 
N-acetylcysteine inhibits UV-A activation of AP-1 without 
affecting lipid peroxidation. Such a difference in the effect of 
these two antioxidants may be explained by their distinct 
mechanisms of action. Indeed, the hydrophobic vitamin E is 
localized inside the lipid phase of the cell membrane and can 
only act as a radical scavenger in the membrane nvironment 
of the cell [20]. On the other hand, the hydrophilic N-acetyl- 
cysteine, precursor of glutathione, can pass through the cell 
membrane and play a role in the regulation of the intracellular 
redox state of the cell by donation of an electron or a hydro- 
gen atom from the sulphur moiety [21]. It is possible that UV- 
A perturbs the redox states of cellular proteins. This is con- 







Fig. 3. Characterization f UV-A induced AP-1-DNA complexes. 
Nuclear extracts prepared from NCTC 2544 cells irradiated with 
190 kJ/m2 UV-A were assayed for AP-1 binding activity with or 
without 2 mg of anti-c-Jun (lane 2) or anti-c-Fos (lane 3) antibod- 
ies, or in the presence of a 300-fold excess of an unlabeled oligonu- 
cleotide containing AP-I sites (lane 4) or a 100-fold excess of an un- 
labeled oligonucleotide containing the Oct-1 consensus equence 
(lane 5). 
tects human skin fibroblasts against the cytotoxic effect of 
UV-A [22]. These results are also in accordance with previous 
findings which reported the UV radiation protecting efficacy 
of cysteine derivatives uch as N-acetylcysteine [23,24]. It is 
interesting to note that the modification of cysteine residues 
on the DNA binding domain of c-Jun and c-Fos can modu- 
late AP-1 activity [25]. In addition, it has been reported that 
Nac prevents the UV-C dependent stimulation of sre tyrosine 
kinase activity which mediates the UV-C induced activation of 
AP-1 [26,27]. Thus, the redox sensitive kinase cascades in- 
volved in AP-1 signaling may be targets of UV-A radiation. 
In conclusion, our study provides the first evidence that 
UV-A radiation induces AP-1 activation in human cells. 
This response is sensitive to a perturbation of the cellular 
redox equilibrium. It is known that many promoters that 
are active in terminally differentiating epidermal cells contain 
functionally important AP-1 sites [28]. In this regard, the pro- 
tective or degenerative role played by the UV-A induced acti- 
vation of AP-1 in skin cells deserves further investigation. 
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